Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AcneFree is a brand of over-the-counter topical skincare formulations marketed for the treatment and prevention of acne. The products are generally sold as multi-step kits or individual treatments that target excess oil, clogged pores, and acne-causing bacteria. The core mechanism of action is the antimicrobial activity of benzoyl peroxide, which penetrates into pores to kill Cutibacterium acnes (the primary acne-causing bacterium) and reduce inflammation. Complementary ingredients include retinol (promoting exfoliation and skin cell turnover), witch hazel (astringent and mattifying effect), glycolic acid (alpha-hydroxy acid for exfoliation), niacinamide (anti-inflammatory and sebum-regulating), and others that support skin hydration and barrier function. AcneFree products are designed for daily topical application and are formulated to address mild to severe acne through a combination of active and supporting ingredients[1][2][5][10][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AcneFree.